CRP and non-small cell lung carcinoma: Although several studies have shown that baseline CRP level may be a promising predictor of response to ICI treatment in advanced NSCLC [22–26], the inclusion of a control arm in our study provides further evidence to confirm the predictive nature of CRP, distinguishing it from its prognostic value.